Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
Status:
RECRUITING
Trial end date:
2030-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the induction chemotherapy efficacy in olfactory neuroblastoma. The main question it aims to answer is: wether olfactory neuroblastoma patients with different pathology subtypes apply to different induction chemotherapy schemes. Participants will be treated with different chemotherapy schemes, to evaluate the tumor remission rate and long term survival.